Paul F. Riska, M.D.

Medicine

Phone718-920-8542
Emailpriska@montefiore.org
Websitehttp://www.einstein.yu.edu/faculty/1700/paul-riska/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Paul F. Riska is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

11 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Finished

MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS
Riska, P. F.
National Institute of Allergy and Infectious Diseases
7/15/98 → 6/30/04
Project: Research project

1146 Citations
19 h-Index
30 Article
1 Review article

The emperor's new clothes: Prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with methicillin-resistant staphylococcus aureus bloodstream infections (PROVIDE)
Antibacterial Resistance Leadership Group, Apr 15 2020, In: Clinical Infectious Diseases. 70, 8, p. 1536-1545 10 p.
Research output: Contribution to journal › Article › peer-review
25 Scopus citations
Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial
INSIGHT FLU-IVIG Study Group, Nov 2019, In: The Lancet Respiratory Medicine. 7, 11, p. 951-963 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
41 Scopus citations
Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia a randomized clinical trial
the Staphylococcal Bacteremia Investigators, Sep 25 2018, In: JAMA - Journal of the American Medical Association. 320, 12, p. 1249-1258 10 p.
Research output: Contribution to journal › Article › peer-review
27 Scopus citations
Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study
For the INSIGHT FLU003 Plus Study Group, Jan 1 2018, In: Open Forum Infectious Diseases. 5, 1, ofx228.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Two for the price of one: Emerging carbapenemases in a returning traveller to New York City
Mittal, J., Szymczak, W. A., Guo, Y., Levi, M. H., Chen, L., Kreiswirth, B. N., Riska, P. F. & Nori, P., 2018, In: BMJ case reports. 2018, bcr-2018-225440.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations

MYCOBACTERIOPHANGE INTERACTION WITH M TUBERCULOSIS

The emperor's new clothes: Prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with methicillin-resistant staphylococcus aureus bloodstream infections (PROVIDE)

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

Effect of algorithm-based therapy vs usual care on clinical success and serious adverse events in patients with staphylococcal bacteremia a randomized clinical trial

Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

Two for the price of one: Emerging carbapenemases in a returning traveller to New York City